US 2017/0000757 A1Published application

Therapeutic application of (boc)2-creatine

AssigneeUniversita' Degli Studi Di Genova

InventorsPatrizia GARBATI, Maurizio BALESTRINO, Enrico ADRIANO, Silvia RAVERA, Enrico MILLO, Gianluca DAMONTE, Annalisa SALIS

Life of this patent

Estimating the term…

A creatine derivative, (Boc)2-creatine, is used as a medicament, in particular in a therapeutic antitumor treatment. I (Boc)2-creatine.

Dependent claims

The compound (Boc)2-creatine for use as a medicament.

Dependencies are inferred from the claim text.

A61K 31/325
Medicinal preparations containing organic active ingredients: carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
A61K 31/27
Esters, e.g. nitroglycerine, selenocyanates: of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…
A61P 35/00
Antineoplastic agents

From the US filing history. Foreign family members aren’t listed.

Loading patent…